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CONSPECTUS
B
ioorthogonal reactions are chemical reactions that neither interact with nor interfere with a biological system. The
participating functional groups must be inert to biological moieties, must selectively reactive with each other under
biocompatible conditions, and, for in vivo applications, must be nontoxic to cells and organisms. Additionally, it is helpful if one
reactivegroup issmallandtherefore minimally perturbingofabiomolecule into whichit hasbeenintroduced eitherchemically or
biosynthetically.Examplesfromthepastdecadesuggestthatapromisingstrategyforbioorthogonalreactiondevelopmentbegins
with ananalysis of functional group and reactivity space outside those defined byNature. Issuessuch as stability ofreactants and
products(particularlyinwater),kinetics,andunwantedsidereactivitywithbiofunctionalitiesmustbeaddressed,ideallyguidedby
detailed mechanistic studies. Finally, the reaction must be tested in a variety of environments, escalating from aqueous media to
biomolecule solutions to cultured cells and, for the most optimized transformations, to live organisms.
Work in our laboratory led to the development of two bioorthogonal transformations that exploit the azide as a small, abiotic, and
bioinert reaction partner: the Staudinger ligation and strain-promoted azide alkyne cycloaddition. The Staudinger ligation is based on
theclassicStaudingerreductionofazideswithtriarylphosphinesfirstreportedin1919.Intheligationreaction,theintermediateaza-ylide
undergoesintramolecularreactionwithanester,forminganamidebondfasterthanaza-ylidehydrolysiswouldotherwiseoccurinwater.
TheStaudingerligationishighlyselectiveandreliablyformsitsproductinenvironsasdemandingaslivemice.However,theStaudingerligation
has some liabilities, such as the propensity of phosphine reagents to undergo air oxidation and the relatively slow kinetics of the reaction.
The Staudinger ligation takes advantage of the electrophilicity of the azide; however, the azide can also participate in
cycloadditionreactions.In1961,WittigandKrebsnotedthatthestrained,cyclicalkynecyclooctynereactsviolentlywhencombined
neatwithphenylazide,formingatriazoleproductby1,3-dipolarcycloaddition.Thisobservationstoodinstarkcontrasttotheslow
kinetics associated with 1,3-dipolar cycloaddition of azides with unstrained, linear alkynes, the conventional Huisgen process.
Notably, the reaction of azides with terminal alkynes can be accelerated dramatically by copper catalysis (this highly popular Cu-
catalyzed azide alkyne cycloaddition (CuAAC) is a quintessential “click” reaction). However, the copper catalysts are too cytotoxic
for long-term exposure with live cells or organisms. Thus, for applications of bioorthogonal chemistry in living systems, we built upon
WittigandKrebs'observationwiththedesignofcyclooctynereagentsthatreactrapidlyandselectivelywithbiomolecule-associatedazides.
This strain-promoted azide alkyne cycloaddition is often referred to as “Cu-free click chemistry”. Mechanistic and theoretical studies
inspired the design of a series of cyclooctyne compounds bearing fluorine substituents, fused rings, and judiciously situated heteroatoms,
with the goals of optimizing azide cycloaddition kinetics, stability, solubility, and pharmacokinetic properties. Cyclooctyne reagents have
now been used for labeling azide-modified biomolecules on cultured cells and in live Caenorhabditis elegans, zebrafish, and mice.
As this special issue testifies, the field of bioorthogonal chemistry is firmly established as a challenging frontier of reaction
methodology and an important new instrument for biological discovery. The above reactions, as well as several newcomers with
bioorthogonal attributes, have enabled the high-precision chemical modification of biomolecules in vitro, as well as real-time
visualizationofmoleculesandprocessesincellsandliveorganisms.Theconsequenceisanimpressivebodyofnewknowledgeand
technology, amassed using a relatively small bioorthogonal reaction compendium. Expansion of this toolkit, an effort that is
already well underway, is an important objective for chemists and biologists alike.Vol. 44, No. 9 ’ 2011 ’ 666–676 ’ ACCOUNTS OF CHEMICAL RESEARCH ’ 667
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Introduction
Asscientists,wehavemuchtolearnregardingthemolecular
interactions and chemical transformations that enable life.
Genomicdatahaveilluminatedmanyaspectsofproteinand
nucleic acid expression and regulation. However, other
biomolecules such as glycans, lipids, and metabolites, on
their own or as posttranslational modifications, are impos-
sible to interrogate using genomic data alone. Additionally,
biology-driven experimental approaches do a poor job in
these sectors of biochemistry, particularly when the goal is
to monitor spatiotemporal dynamics of the target biomole-
cules in cells or model organisms. This technology deficit
prompted us to look toward chemical means to study
biological processes, and ultimately, motivated our interest
in developing bioorthogonal chemical reactions.
Areactionclassifiesasbioorthogonalifitneitherinteracts
nor interferes with a biological system (Figure 1A).
1 Our first
published use of the term “bioorthogonal” occurred in
2003,
2 although we often used this concise descriptor in
public presentations during our earlier work in the late
1990s. Historically, the concept of bioorthogonality has
strong roots in the much older field of bioconjugation,
wherein a classic challenge was to identify selective beha-
viors of amino acid side chains that could be exploited for
chemical modification in vitro. However, targeted modifica-
tion of a protein or any other biomolecule in vivo would
require a chemical reaction among functionalities that are
not so prevalent among (and ideally are absent from)
natural biomolecules. A few isolated reports from the
1990s suggested that such chemical reactions might exist
or least could be invented with some clever mechanistic
thinking. As far back as 1990, Rideout and co-workers
demonstrated that the selective condensation of hydrazine
andaldehydegroupscouldbeharnessedtoassembletoxins
from inactive prodrugs within live cells.
3 Then, in 1998,
Tsien and co-workers rocked the chemistry world with the
first example of live cell protein labeling using bisarsenical
dyes.
4 These early examples foreshadowed the power of
bioorthogonal chemistry as an instrument for biological
discovery and biotechnology. But perhaps more impor-
tantly, they empowered chemists to consider developing
chemical reactions explicitly tailored for use in biological
systems.Growinginterestinthischallengeisunderscoredby
widespread adoption of the term “bioorthogonal” by the
chemistry community since that time, as evidenced by an
expanding number of publications containing this term
(Figure 2).
Nowadays, the use of bioorthogonal chemistry to probe
biomolecules in living systems typically follows a two-step
process. First, a metabolic substrate, small molecule ligand,
or enzyme inhibitor is adorned with one of the bioorthogo-
nal functional groups and introduced to the biological sys-
tem. The structural perturbation imposed by that functional
group, also referred to as a “chemical reporter”, must be
minimal so as not to undermine the molecule's natural
bioactivity. Once the labeled molecule has been delivered
to its target (e.g., a metabolically labeled glycan, lipid, or
protein or an inhibitor-bound receptor or enzyme), the
second step involves a bioorthogonal chemical reaction
with an appropriately functionalized probe (Figure 1B). A
number of creative approaches have now been developed
to deliver bioorthogonal functional groups to biomolecules
in cells and model organisms.
1 In retrospect, this aspect of
the experimental platform has been relatively straightfor-
ward.Bycontrast,developingandoptimizingbioorthogonal
reactions, the synthetic methodology component of the
platform, continues to be a significant challenge.
From a chemist's perspective, bioorthogonal reaction
developmenthasunusuallyrestrictiveboundaryconditions.
The reaction must form a stable covalent linkage between
two functionalgroups that arebioinertandideally nontoxic.
The reaction must have fast kinetics so that product is
formed at a reasonable rate even when reactant concentra-
tions are very low, as is required in many biological labeling
experiments.Also,suchfastkineticsmustbeachievedinthe
physiological ranges of pH and temperature. For optimal
FIGURE 1. (A) A generic bioorthogonal chemical reaction between X
and Y that proceeds in biological systems. (B) A common experimental
platformforbiomoleculeprobingusingbioorthogonalchemistry.First,a
non-native functional group, often called a “chemical reporter”,i s
installed in a biomolecule of interest. The modified biomolecule is
subsequently labeled using a bioorthogonal chemical reaction.668 ’ ACCOUNTS OF CHEMICAL RESEARCH ’ 666–676 ’ 2011 ’ Vol. 44, No. 9
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utility as chemical reporters, at least one of these functional
groups should be small as well.
Considering all of the above requirements, one might
arguethattheperfectbioorthogonalreactionhasyettobe
reported, though a number of transformations are ap-
proachingtheideal.InthisAccount,weproposeastrategy
todevelopbioorthogonalreactionsthathas foundvalida-
tion in stories from our lab, specifically the Staudinger
ligationandstrain-promotedazide alkynecycloaddition,
alsotermed“Cu-freeclickchemistry”.Wealsodiscussgaps
in existing reaction methodology where there is need for
future optimization. Applications of these reactions and
the development of new bioorthogonal chemistries are
highlighted in other contributions to this special issue of
Accounts of Chemical Research.
A Guide for Bioorthogonal Reaction
Development
The process of bioorthogonal reaction development and
optimization is a journey that requires a critical under-
standing of mechanistic chemistry, biochemistry, and, for
in vivo applications, pharmacology and metabolism. The
effort begins with an analysis of those functionalities and
reaction types that are not represented among Nature's
repertoire. From this abiotic chemical space, a prototype
reaction among functional groups with inherent stability
toward biological moieties, nucleophiles, reductants, and
of course, water, is identified (Figure 3, step 1). In our
experience, the chemical literature from the early to mid-
20th century is fertile ground for unearthing prototype
reactions. During this period, physical organic chemists
were intrigued by the properties of exotic structures out-
side of mainstream of organic synthesis, and the practical
utilityofsomeofthesemechanisticodditieswasgenerally
notofprimaryimportance.Understandingthefundamen-
tal behaviors of organic molecules, how structure relates
to reactivity, was sufficient justification for such mechan-
istic explorations, a testament to a time when society was
more forgiving of curiosity-driven science.
Once a prototype reaction is selected, an in-depth me-
chanistic analysis is essential to guide the requisite adapta-
tionsforuseinbiologicalsystemsandtoanticipatepotential
pitfalls(Figure3,step2).Eachelementarystepofthereaction
must be compatible with water and the large excess of
nucleophilic functionalities found in Nature (e.g., amines,
thiols, hydroxy groups). These elementary steps must pro-
ceed at reasonable rates under physiological conditions. In
practice,reactionswithasecond-orderrateconstantsmaller
than 10
 4 M
 1 s
 1 will be too slow for practical use when
reagents are held at the low concentrations necessary to
label biomolecules with minimal background. For this rea-
son, rate enhancement is a common initial goal in trans-
forming a prototype reaction to a bona fide bioorthogonal
transformation.
The next step (Figure 3, step 3) is to modify the reagents,
andinsomecasestheoverallmechanism,tosolvewhatever
problems are revealed in step 2. Adjustments might include
the addition of steric bulk for protection from biological
nucleophiles, exchange of heteroatoms to promote optimal
orbital interactions, or activation of the reagents by strain
enhancement or electronic perturbation. The mechanistic
modifications are the most difficult part of the reaction
development process, and chemists often find themselves
pursing numerous iterations of a reaction along the way.
Once the optimized candidate reaction proceeds effi-
ciently in a flask, it must be tested against the standards of
bioorthogonality in environments of increasing complexity
(Figure 3, steps 4 7). The first test is whether the reaction
proceeds reliably in aqueous media alongside biological
metabolites such as amino acids and sugars (step 4). Next,
the reaction must be evaluated on biomolecules (step 5), in
FIGURE 3. A step-by-step guide to developing a bioorthogonal
reaction.
FIGURE 2. The number of publications containing the word “bioortho-
gonal” categorized by year of publication. *The 2011 value is projected
based on publications from the first half of the year. Source: SciFinder
Scholar.Vol. 44, No. 9 ’ 2011 ’ 666–676 ’ ACCOUNTS OF CHEMICAL RESEARCH ’ 669
From Mechanism to Mouse Sletten and Bertozzi
livecells(step6),andultimately,inmodelorganismssuchas
zebrafish or mice (step 7). Not all bioorthogonal reactions
developedtodatehavesucceededinliveanimals,orevenin
live cells, but these decisive measures of bioorthogonality
should always be considered a central goal.
The final criterion of a superior bioorthogonal reaction
is that at least one of its participating functional groups
c a nb ei n c o r p o r a t e di n t ob i o m o l e c u l e si nl i v i n gs y s t e m s
(Figure 3, step 8). In reality, step 8 is often pursued in
parallel to steps 6 and 7. Numerous methods for installing
unnatural functional groups within proteins, glycans, li-
pids, nucleic acids, and other metabolites have been
developed.
1Thefunctionalgroupswithaccesstothemost
extensive list of biomolecules, typically the smallest func-
tional groups, are those whose bioorthogonal reactions
will ultimately be the most useful.
TheStaudinger LigationInitiatesaNewErain
Bioorthogonal Chemistry
The Staudinger ligation essentially launched the field of
bioorthogonal chemistry, not because it was the first bioortho-
gonalreactionperse,butbecauseitwasthefirstamongentirely
abiotic functional groups and therefore had the potential for
translation to live organisms.
5 Its prototype reaction was the
iconic Staudinger reduction of azides with triphenylphosphine
andwater(Figure4A),afamouslymildtransformationthatwas
reported by Hermann Staudinger in 1919.
6 Features that
caught our attention were the small size of the azide, its kinetic
stability, and its absence from biological systems. Also, the
azide's behavior as a “soft electrophile” that prefers “soft
nucleophiles” (such as phosphines) situates the functional
g r o u pi nar e a c t i o ns p a c et h a ti sd i s t i n c tf r o mm o s to fb i o l o g y ,
wherein nucleophiles are typically “hard”. That organic azides
would be well tolerated by cells and organisms was hinted at
bytheestablished useof arylazidesasphoto-cross-linkersand
by the favorable toxicity profiles of commercially approved
drugs such as azidothymidine. Additionally, phosphines, the
other reactive group, are naturally absent from living systems.
Mechanistically, the classic Staudinger reduction (Figure 4A)
proceeds through nucleophilic attack of the phosphine (2)o n
the azide (1) followed by loss of nitrogen to yield an aza-ylide
species (3). In aqueous environments, the aza-ylide is rapidly
hydrolyzed to produce a phosphine oxide (4) and an amine (5).
The Staudinger reduction appeared well-suited as a prototype
for bioorthogonal reaction development because the two
participants were abiotic, mutually and selectively reactive,
mostly unreactive with biological functionalities, and tolerant
ofwater.Themainproblemwasthattheinitialcovalentlinkage
formed (intermediate 3)w a sl a t e rl o s tt oh y d r o l y s i s .T h u s ,a
mechanistic modification was needed to redirect the aza-ylide
intermediate to a stably ligated product. This was achieved by
introducing an ester group ortho to the phosphorus atom on
one of the aryl rings (6, Figure 4B). Formation of the aza-ylide
intermediate (7) proceeded analogously to the Staudinger
reduction; however, the ester group offered a new path of
reactivity in which the nucleophilic nitrogen atom reacted with
this electrophilic trap to form intermediate 8,w h i c h ,u p o n
hydrolysis, yielded a stable amide-linked product (9).
5
This adjustment to the prototype reaction was sufficient
to generate a bioorthogonal chemical reaction. The engi-
neered phosphines were exquisitely selective for azides
evenwhensurroundedbybiofunctionalityasdemonstrated
by the selective tagging of azide-labeled glycoproteins with
phosphine probes in cell lysates (Figure 5A,B).
7 Addition-
ally,thetworeactants proved tobe surprisinglynontoxic,
and therefore the Staudinger ligation can be performed
on live cells. Flow cytometry data from a typical experi-
ment in which cell-surface glycans were labeled with
azidosugars and then reacted with a phosphine probe
are shown in Figure 5C.
4 Finally, the Staudinger ligation
was performed in live mice, enabling the selective in vivo
covalent modification of cell-surface glycans with chemi-
cal probes (Figure 5D).
8 This unprecedented feat was a
FIGURE 4. The mechanism of the Staudinger reduction (A) and Stau-
dinger ligation (B).670 ’ ACCOUNTS OF CHEMICAL RESEARCH ’ 666–676 ’ 2011 ’ Vol. 44, No. 9
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testament to the mutual selectivity of the Staudinger ligation
reagents; no previously reported reaction could have reliably
formed products in such a complex reaction vessel. But the real
gem of this early work was the azide. The benefits of its small
size were immediately apparent as we found that several
glycan biosynthetic pathways were quite accommodating of
azidosugar substrates. Since that initial work, many other
groups have used the azide as a chemical reporter of protein
biosynthesis, lipid posttranslational modifications, nucleic acid
biosynthesis,enzymeactivity,andthelistkeepsgrowing(many
examples are highlighted in this issue).
1
The Staudinger ligation possessed unmatched capabil-
ities, but it fell short of perfection. The phosphine reagents
slowly underwent air oxidation within biological systems
and were probably metabolized by cytochrome P450 en-
zymesinmice.Additionally,thekineticsofthereactionwere
somewhat slow (typical second-order rate constant of
0.0020 M
 1 s
 1), which necessitated the use of high con-
centrations of phosphine reagent.This,inturn, wasfound to
be problematic for fluorescence imaging applications since
excessprobereagentwasdifficulttowashaway,resultingin
high background signal.
9
A detailed mechanistic study revealed that the rate-
determining step of the Staudinger ligation is the initial
nucleophilic attack of the phosphine on the azide.
10 Thus,
increasing the electron density on the phosphorus atom
could, in principle, increase the rate of the Staudinger liga-
tion. While the addition of electron-donating groups to the
aryl substituents did indeed increase the rate of the desired
reaction, these more reactive substrates were also rapidly
oxidized in air.
Frustrated by our inability to improve the intrinsic
kineticsof theStaudinger ligation, we turned toalternate
meansofreducingbackgroundfluorescenceincellimag-
ing experiments. A key step in the reaction mecha-
nism is intramolecular amide bond formation with
concomitant ester cleavage. Our mechanistic studies
indicated that the alcohol leaving group could be varied
widely in structure without detriment to rate or yield.
10
We exploited this feature to design a fluorogenic phos-
phine reagent (10,Q P h o s ,F i g u r e6 A ) .
11 Fluorescein was
conjugated to one of the phosphine's aryl substituents
through an amide linkage; a FRET quencher, disperse
FIGURE 5. The Staudinger ligation enables selective biomolecule la-
beling in a variety of environments. (A) A phosphine biotin (Phos-
biotin) probe for detection of azides through the Staudinger ligation.
(B,C)Selectivelabelingofazide-modifiedglycoproteinsinlysatesandon
livecells.Jurkatcellsweretreatedwith(bluebars)orwithout(greenbars)
peracetylated-N-azidoactyl mannosamine (Ac4ManNAz), which is me-
tabolized to N-azidoacetyl neuraminic acid and incorporated into gly-
coproteins.(B)LysatesweretreatedwithPhos-biotin(250μM)overnight
and analyzed byWesternblot probingwithananti-biotin horseradish
peroxidase (HRP) antibody. (C) Live cells were treated with Phos-biotin
(250 μM) for 1 h, followed by incubation with a fluorescent avidin
protein (FITC-avidin) and analyzed by flow cytometry. (D) Mice were
injected with (blue bars) or without (green bars) Ac4ManNAz once daily
for 7 d. On the eighth day, phosphine conjugated to the FLAG peptide
(Phos-FLAG) was injected into the mice. After 3 h, the mice were
sacrificed, and their splenocytes were isolated, incubated with a fluo-
rescent anti-FLAG antibody (FITC-anti-FLAG), and analyzed by flow
cytometry. Au = arbitrary units.
FIGURE 6. (A) A FRET-based fluorogenic phosphine for the Staudinger
ligation.(B,C)HeLacellsweregrowninthepresence(B)orabsence(C)of
Ac4ManNAz.The cells were washed, incubated with 50 μM 10 for 8 h at
37 C, and imaged. Green = fluorescein. Blue = Hoechst 33342 nuclear
stain. Images were originally published in ref 11. Copyright 2008,
WILEY-VHC. (D) A phosphine luciferin probe for bioluminescence
imaging of azides.Vol. 44, No. 9 ’ 2011 ’ 666–676 ’ ACCOUNTS OF CHEMICAL RESEARCH ’ 671
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red-1, was appended through the ester linkage. Upon
reaction with an azide, the quencher was released to
yield a fluorescent product. QPhos allowed for direct
imaging of azides on live cultured cells (Figure 6B,C).
The slow reaction kinetics of the Staudinger ligation,
coupled with the imperfect spectral properties of fluorescein
for in vivo imaging, have to date undermined the use of
fluorogenic phosphine 10 in live animals. Red-shifted var-
iants of the fluorogenic phosphine have been synthesized,
but these compounds undergo rapid nonspecific phosphine
oxidation.
12 Recently, we redirected our in vivo imaging
efforts to the more sensitive imaging modality of biolumi-
nescence, and toward this end, we reported bioluminogenic
phosphine reagent 11 (Figure 6D).
13 Like fluorogenic re-
agent 10, compound 11 releases luciferin during its Stau-
dinger ligation with phosphines. Once liberated, luciferin
readily enters cells wherein heterologously expressed luci-
ferase catalyzes its oxidation and the concomitant emission
of light. Compound 11 enabled very sensitive detection of
azides within cell-surface glycoproteins and is a promising
reagent for in vivo imaging in luciferase transgenic mice.
Since its original inception, the Staudinger ligation has
found utility far beyond glycan imaging. The reaction has
been employed for glycoproteomics studies
14 and for im-
mobilization of azide-labeled proteins on surfaces.
15 Addi-
tionally, a modified version of the Staudinger ligation, the
“traceless” Staudinger ligation, has been used for protein
synthesis in a manner reminiscent of native chemical
ligation.
16,17 For this application, another mechanistic mod-
ification was made so that the phosphine oxide is expelled
duringthereaction,leavinganunencumberedamide-linked
product.
While still the reaction of choice for a wide range of
bioconjugation applications, the slow kinetics of the Stau-
dinger ligation remains an unsolved problem and an ob-
stacle for in vivo chemistry. Consequently, during the mid-
2000s, we and others turned our attention to the other
mode of bioorthogonal reactivity exhibited by the azide:
its 1,3-dipolar cycloaddition with alkynes.
Cu-Free Click Chemistry
The cycloaddition reaction of azides and alkynes to form
triazoles (Figure 7A) was first reported by Michael in the late
1890s
18 and later studied in depth by Huisgen in the mid-
20th century.
19 Huisgen spent a great deal of his career
analyzing the mechanism of this and other [3 þ 2] cycload-
ditionreactions,
19andconsequently,therewasalargebody
ofphysicalorganicchemistryonecouldexploitinconverting
this prototype to a bioorthogonal reaction. Similar to the
Staudingerligation,themajordeficiencyofthecanonical
azide alkyne cycloaddition was its sluggish kinetics
using conventional unactivated alkynes.
20 Indeed, the
standard Huisgen reactions were typically performed at
elevated temperatures and pressuresthat arefar beyond
the limits of biological systems.
In the early 2000s, Sharpless and Meldal also noted the
potential utility of the Huisgen cycloaddition as a means to
selectively couple highly functionalized molecules. They
independently reported that a dramatic rate enhancement
of the reaction with terminal alkynes can be achieved using
a Cu(I) catalyst (Figure 7B).
21,22 Today this reaction is con-
sidered a paragon of “click chemistry” and has been used in
many fields of chemistry, including chemical biology.
23 It is
nearly bioorthogonal, with the major liability being that the
Cu(I) catalyst is cytotoxic. Several laboratories are working
toward decreasing the cytotoxicity or increasing the reactiv-
ity of the catalyst through ligand optimization. Recent suc-
cessinthisareahasallowedforlivecellimagingofazideand
terminal alkyne chemical reporter groups.
24,25
We sought to avoid the use of tranisition metal catalysts
altogether, hoping that a more biofriendly method of acti-
vating alkynes toward reaction with azides could be found
by mining the classic mechanistic literature. Sure enough, in
1961, Wittig and Krebs reported that cyclooctyne, the smal-
lest stable cycloalkyne, reacted “like an explosion” with
phenyl azide.
26 We inferred from this statement that a good
portion of the ∼18 kcal/mol of ring strain associated with
cyclooctyne was released in the transition state of the
cycloaddition reaction.
Motivated by this report of a putative “Cu-free click
chemistry”, we embarked on the synthesis of strained
FIGURE 7. (A) The 1,3-dipolar cycloaddition of azides and linear
alkynes to form regioisomeric triazole products. (B) The Cu(I)-catalyzed
formal azide alkyne cycloaddition to yield 1,4-triazole products, also
known as CuAAC, a paradigm example of “click chemistry”. (C) The
strain-promoted cycloaddition of azides and cyclooctynes to give
triazole products, also known as Cu-free click chemistry.672 ’ ACCOUNTS OF CHEMICAL RESEARCH ’ 666–676 ’ 2011 ’ Vol. 44, No. 9
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cyclooctynes that were also functionalized for the attach-
ment of biological probes (Figure 7C). The first in class was
thecompoundwecallOCT,whichweconjugatedtobiotin
for cell labeling studies (Figure 8A).
27 Linear alkynes are
essentially unreactive with azides at physiological tem-
perature, but OCT-biotin readily reacted with azide-
labeled glycans on proteins, within cell lysates, and on live
cultured cells (Figure 8B,C). Most importantly, the com-
pound exhibited no apparent toxicity, in stark contrast to
the reagents for the Cu-catalyzed reaction. However, with
a second-order rate constant of 0.0024 M
 1 s
 1 in model
reactions, OCT (12, Figure 9) was no faster than the
Staudingerligation.Thecompoundalsohadlimitedwater
solubility.
We embarked on a series of mechanism-based modifica-
tions to accelerate the reaction and improve its physical
properties for in vivo imaging applications. The “aryl-less
octyne” 13 (ALO) had better water solubility, but its kinetic
properties were similar to those of OCT.
28 The first signifi-
cant rate enhancement was achieved by addition of an
electron-withdrawingfluorineatomatthepropargylicposition
to yield a monofluorinated cyclooctyne (MOFO, 14). MOFO
proved more reactive than OCT and ALO (k= 0.0043 M
 1s
 1)
and, accordingly, labeled azides in cell lysates and on cell-
surfaces more rapidly.
28 Even more dramatic was the
addition of a gem-difluoro group at the propargylic posi-
tion, creating difluorinated cyclooctyne 15 (DIFO), which
increased the rate of Cu-free click chemistry by more than
an order of magnitude (k =0 . 0 7 6M
 1 s
 1).
29 Boons and
co-workerslaterreportedthatasimilarrateenhancement
can be achieved by fusing two aryl rings to the cyclooc-
tyne core, resulting in a highly strained dibenzocyclooc-
tyne 16 (DIBO, k =0 . 0 5 7M
 1 s
 1).
30 We were able to
achieveanotherorderofmagnituderateincreasethrough
the addition of an amide bond to the DIBO scaffold,
yielding a biarylazacyclooctynone (BARAC, 17, k =0 . 9 6
M
 1 s
 1).
31 A version of BARAC with an exocyclic amide
(18) was prepared independently by the Van Delft and
Popik groups (named DIBAC or ADIBO) and its reaction
with azides was associated with a rate-constant of 0.31 M
 1
s
 1.
32,33 Additionally, photocaged
34 and tetramethoxy
35 ver-
sions of DIBO (19, 20) have been reported, as well as a
keto-DIBO (21) that undergoes spectral changes upon
FIGURE 8. Cyclooctyne selectively reacts with azides through a strain-
promoted cycloaddition. (A) A cyclooctyne biotin probe (OCT-biotin).
(B) OCT selectively labels an azide-modified form of the recombinant
glycoprotein GlyCAM-IgG. Purified GlyCAM-IgG or azido-GlyCAM-IgG
wasincubatedwith0or250μMOCT-biotinovernightatrt.Thesamples
were analyzed by Western blot probing with an anti-biotin antibody
conjugated to HRP. An anti-IgG antibody confirmed equal protein
loading. Western blot reprinted with permission from ref 27. Copyright
2004 American Chemical Society. (C) OCT labels live cells in an azide-
dependent manner. Jurkat cells were grown in the presence (blue bars)
or absence (green bars) of Ac4ManNAz. The cells were incubated with
OCT-biotin or Phos-biotin (100 μM) for 1 h at rt, followed by treatment
with FITC-avidin, and analyzed by flow cytometry.
FIGURE9. CyclooctynessynthesizedforCu-freeclickchemistryinliving
systems. The second-order rate constants are for the reaction with
benzyl azide in acetonitrile (12,
27 13,
28 14,
28 15,
29 17,
31 22
42)o r
methanol (16,
36 18,
32 19,
34 20,
35 21
36).Vol. 44, No. 9 ’ 2011 ’ 666–676 ’ ACCOUNTS OF CHEMICAL RESEARCH ’ 673
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triazole formation with azides.
36 These diverse cyclooctynes
demonstrate the value of mechanistic modifications in trans-
forming an obscure chemical reaction from the mid-20th
century literature into a highly efficient bioorthogonal ligation.
The second-order rate constants for their cycloaddition
reactions with azides accurately reflected the cyclooctynes'
ability todetectazides inbiologicallabeling experiments.As
shown in Figure 10A, DIFO reagents chemically labeled cell
surface azides with far greater sensitivity than comparable
phosphinereagents.Aswell,cellsurfacelabelingefficiencies
of DIFO, DIBO, and BARAC directly correlated with their
relative reactivities (Figure 10B).
29 31 All three cyclooctynes
have been conjugated to fluorophores for direct imaging of
azidosugars on live cells (Figure 11).
29 31,37 The heightened
reactivity of BARAC enabled imaging with such low probe
concentrations that removal of excess probe via washing
steps was not necessary.
The first application of bioorthogonal chemistry to in vivo
imaging, a landmark in the field, was achieved using
the reaction of DIFO with azides. We employed DIFO 
Alexa Fluor conjugates (DIFO-488, DIFO-555, etc.) to probe
spatiotemporal changes in cell-surface glycosylation in
Caenorhabditis elegans and in developing zebrafish. With
peracetylated N-azidoacetylgalactosamine (Ac4GalNAz) as
a metabolic label, glycoproteins were imaged during three
stages of C. elegans development, and significant labeling
was observed in the pharynx, vulva, and anus (Figure 12A).
38
In a similar manner, GalNAz-labeled glycoproteins in
zebrafish embryos were imaged between 60 and 73 h
postfertilization (hpf), and dynamic labeling was moni-
tored in the pectoral fins, olfactory pit, and jaw. Glycan
trafficking between 60 and 72 hpf was further analyzed
through pulse chase experiments with spectrally dis-
tinct DIFO conjugates (Figure 12B).
39 Glycans expressed
during earlier stages of zebrafish embryogenesis could
be detected by direct microinjection of GalNAz or the
advancedmetaboliteUDP-GalNAzintotheyolkofsingle-
cellembryos.Usingthistechnique,azidoglycanscouldbe
imaged as early as 7 hpf (Figure 12C).
40
Themouseisamoreversatilemodelforstudiesofhuman
disease, particularly cancer, and therefore we sought to use
DIFO probes for in vivo imaging in this organism. However,
the fast kinetics of the reaction of DIFO with azides ex vivo
did not translate to an efficient reaction in mice. Indeed, in a
head-to-head comparison with phosphine probes, DIFO
reagents reacted less efficiently with azide-labeled glyco-
proteins on mouse splenocytes in vivo (Figure 13A).
41 Why
did the sluggish Staudinger ligation outperform the speedy
Cu-free click chemistry with DIFO? We found that DIFO, a
hydrophobic hydrocarbon, binds strongly to the abundant
FIGURE 10. The cyclooctynes are superior reagents for labeling azides
oncellsurfaces.(A,B)Jurkatcellsweregrowninthepresenceorabsence
of Ac4ManNAz. (A) The cells were incubated with Phos-biotin or DIFO-
biotin(100μM)for 1h atrt, followedby treatment withFITC-avidin, and
analyzed by flow cytometry. (B) The cells were treated with BARAC-
biotin, DIFO-biotin, or DIBO-biotin (1 μM) for various amounts of time.
Each sample was incubated with FITC-avidin and analyzed by flow
cytometry. Each point represents the difference between the azide-
treated and untreated cells. Au = arbitrary units.
FIGURE 11. Cyclooctyne fluorophore conjugates label cells in an
azide-dependent manner. CHO (A, B, E H) or U-2 OS (C, D) cells were
grown in the presence (A, C, E, G) or absence (B, D, F, H) of Ac4ManNAz.
(A,B) The cells were incubated with DIFO conjugated to Alexa Fluor 488
(DIFO-488, 100 μM) for 1 min at 37 C, washed, and imaged. (C,D) The
cells were incubated with DIBO conjugated to Alexa Fluor 555 (DIBO-
555,30μM)for1hatrt. Thecellswerethen washed, fixed,andimaged.
(E,F) The cells were incubated with BARAC conjugated to fluorescein
(BARAC-fluorescein,5μM)for5min,washed,andimaged.(G,H)Thecells
were incubated with BARAC-fluorescein (250 nM) for 30 min and imme-
diately imaged without washing. Green = DIFO-488 or BARAC-fluorescein;
Red = DIBO-555; Blue = Hoechst 33342 nuclear stain. (A,B) Images were
reprinted with permission from ref 29. Copyright 2008 National Academy
of Sciences, USA. (C,D) Images reprinted with permission from ref 37.
Copyright 2011 Life Technologies Corporation. (E H) Reprinted with
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serum protein murine serum albumin (MSA), likely resulting
in sequestration from tissue-resident azides.
Torealizethefullpotentialofreactivecyclooctynes,we
sought to improve their solubilities and pharmacokinetic
properties. The more hydrophilic dimethoxyazacyclooc-
tyne (DIMAC, 22, Figure 9)was designed with this purpose
in mind.
42 DIMAC was considerably less reactive with
azides than DIFO (k = 0.0030 M
 1 s
 1). However, DIMAC
was far more water-soluble, which minimized nonspecific
proteinbinding.Still,inmice,DIMAC'simprovedsolubility
properties did not compensate for its sluggish reac-
tion kinetics (Figure 13B).
41 Further optimization of the
cyclooctyne reagents remains necessary to obtain the
optimal balance of reactivity and pharmacokinetic prop-
erties. Analogs of BARAC are promising in this regard,
b e c a u s et h e ya r ev e r yr e a c t i v ea n da l s ob i n dM S Aa t
reduced levels compared with DIFO.
12 The evaluation of
BARAC conjugates as in vivo i m a g i n gr e a g e n t si sa n
i m p o r t a n tn e x ts t e p .
Inadditiontocapturingtheattentionofbiologists,Cu-free
click chemistry has stimulated interest among the current
generation of physical organic chemists, particularly theo-
rists. Several groups have sought to explain the physical
basis of the rate enhancement of cyclooctynes versus linear
alkynesinthecycloadditionreaction,aswellastheeffectsof
fluorination, aryl ring fusions, and other modifications on
reaction kinetics. Using density functional theory (DFT),
Houkandco-workersconcludedthatthebentalkyneangles
withincyclooctyneincreasetherateofthecycloadditiondue
to a minimization of the distortion required to reach the
transition state.
43 Goddard and co-workers have also stu-
died Cu-free click chemistry through DFT calculations and
proposedthatamonobenzocyclooctynewithonefusedaryl
ring would yield an optimal balance between strain en-
hancement and minimization of steric hindrance.
44 Ideally,
this aryl ring would be fused at the 5,6 positions of the
cyclooctyne (23, Figure 14), but 23 was previously shown to
be unstable.
45 However, the notion that cyclooctyne can be
further activated by modifications distal to the reactive site
was recently realized by Van Delft and co-workers. They
demonstrated that bicyclononyne 24 (BCN) has reactivity
similar to DIBAC/ADIBO (k ≈ 0.1 M
 1 s
 1) due to a
combination of strain effects from the fused cyclopropyl
FIGURE13. The Staudingerligationis thesuperior reaction for labeling
cell-surfaceazide-labeledglycoproteinsinmice.(A,B)Micewereinjected
once daily with (blue bars) or without (green bars) Ac4ManNAz for 7 d.
On the eighth day (A) Phos-FLAG or DIFO-FLAG or (B) Phos-FLAG or
DIMAC-FLAG was injected. After 3 h, the mice were sacrificed, and their
splenocyteswereisolated,incubatedwithFITC-anti-FLAG,andanalyzed
by flow cytometry. Au = arbitrary units.
FIGURE 14. Cyclooctynes of recent theoretical and experimental
interest.
FIGURE 12. DIFO Alexa Fluor conjugates label azides in higher or-
ganisms. (A) C. elegans were grown in the presence of Ac4GalNAz and
reacted with DIFO-488 (100 μM) followed by DIFO conjugated to Alexa
Fluor 568 (DIFO-568, 100 μM) and imaged at their adult stage. Image
reprinted with permission from ref 38. Copyright 2009 American
Chemical Society. (B) Zebrafish embryos were metabolically labeled
with Ac4GalNAz from 3 to 60 hpf. The fish were sequentially incubated
with 100 μM DIFO conjugated to Alexa Fluor 647 (DIFO-647, 60 61
hpf), DIFO-488 (62 63 hpf), and DIFO-555 (72 73 hpf) and imaged by
confocal microscopy. During periods in which the zebrafish were not
being labeled with DIFO, the fish were bathed in a solution of Ac4Gal-
NAz.Blue=DIFO-647,Green=DIFO-488,Red=DIFO-555.(C) Zebrafish
embryos were injected with UDP-GalNAz and a rhodamine dextran
tracer dye. At 7 hpf, the embryos were incubated with DIFO-488 (100
μM) for 1 h and imaged by confocal microscopy. Green = DIFO-488,
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group and reduced steric hindrance surrounding the
alkyne.
46
We sought to combine the rate-enhancing modifications
embodied in DIBO and DIFO (fused aryl rings and fluorina-
tion, respectively) by synthesizing difluorobenzocyclooc-
tyne 25 (DIFBO). While the compound reacted rapidly with
azides (k = 0.22 M
 1 s
 1), it was unstable and prone to
oligomerization in concentrated solution.
47 Nonetheless,
DIFBO taught us about the relative contribution of its rate-
enhancing modifications. For comparative purposes, we
preparedmonobenzocyclooctyne26(MOBO)andmeasured
its second-order rate constant to be 0.0095 M
 1 s
 1.
47 Thus,
DIFBO was 20-fold more reactive than MOBO, while MOBO
w a so n l y8t i m e sm o r er e a c t i v et h a nO C T .T h e s er e s u l t s
demonstrate that the electronic effects of propargylic fluorina-
tion are a major contributor to rate enhancement and should
facilitate further optimization of cyclooctynes with regard to
their balance of reactivity and stability.
Theoretical and mechanistic work has contributed im-
portant insights into the design of modified cyclooctynes
withenhancedreactivity.However,Cu-freeclickchemistryis
nottheonlybioorthogonalreactiontobenefitfromtheskills
of physical organic chemists. For example, a recent addition
to the bioorthogonal chemistry compendium, the tetrazine
ligation, was optimized to achieve an impressive rate con-
stant of 22000 M
 1 s
 1 with guidance from theoretical
work.
48Thisinverse-demandDiels Alderreactionbetween
tetrazines and trans-cyclooctenes is the fastest bioorthogo-
nal reaction known to date. These examples highlight the
opportunities for classically trained theoreticians and ex-
perimentalists in this new area of chemical biology.
Conclusion
Bioorthogonal chemistry has evolved to bea rather unusual
field in that it brings together traditional mechanistic chem-
istry,reactionmethodology,cellbiology,andbiomedicine.It
is not surprising then that contributors to this special issue
come from backgrounds as divergent as theoretical chem-
istry and clinical imaging. In our own work summarized
above, we were compelled to characterize fleeting reaction
intermediates, develop new synthetic routes, hunt down
unwanted side products on proteins and cells, track probes
during cellular internalization, disintegrate embryos to map
reaction product distribution, and monitor the health and
well-being of laboratory animals in which we performed
bioorthogonal chemistries. Collaborators were critical for
someofthiswork,becausenosinglelabcanproperlymaster
such a breadth of experimental approaches.
Now in its second decade, the field of bioorthogonal
chemistry offers several lessons. First, the above examples,
as well as many others in this special issue, confirm that
chemical reactions can indeed be designed to perform in
environs as demanding, and also as intriguing, as living
systems. Success in this endeavor requires keen insight into
promising reaction prototypes (and perhaps invention of
new ones looking forward) and diligence in mechanistic
optimization. Second, biologists are eager to embrace tools
from chemistry, but they must be made accessible and
straightforward to execute. Fortunately, several commercial
suppliers now offer azide (or alkyne)-labeled sugars, amino
acids, lipids, and other biomolecular substrates, as well as
complementary probes for detection or enrichment. Such
“kits” enable the use of bioorthogonal chemistry by non-
experts, which is essential for widespread adoption of the
technologyoutsideofchemistrycircles.Thesuccessofthese
commercial kits is no doubt related to the fact that bioortho-
gonal chemistry is intrinsically low-tech; after all, the re-
agents should find each other and react no matter the
complexity of their surroundings. An ideal bioorthogonal
chemical reaction should translate seamlessly from flask
to fish.
A final lesson pertains to the importance of reaction
discovery as the foundation of bioorthogonal chemistry.
The handful of prototype reactions on which current
bioorthogonal transformations are based were discov-
ered long before the chemistry/biology interface was a
fashionable venue for research. Staudinger, Huisgen, and
Wittig could not foresee that their discoveries would
someday lead to methods for in vivo biomolecule ima-
ging. Likewise, contemporary studies of fundamental
chemical reactivity can have an unforeseen impact in
biology and beyond. Suchexplorations should be encour-
aged even if specific applications are not yet on the
horizon. After all, a sector of reaction space that is newly
charted today could produce a prototype for bioorthogo-
nal reaction development tomorrow.
We thank K. Beatty, G. de Almeida, K. Dehnert, J. Jewett, and C.
Gordon for their critical reading of the manuscript. Much of the
work described herein was funded by the National Institute of
Health (GM058867).
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